Since the video taping (as of April 2024), additional data have been published and at least 43 SLE patients have been reported treated with CAR-T cell therapy. Almost all developed mild, easy-to-treat cytokine release syndrome (most common symptom was fever). Therefore, Dr. Thomas retracts his statement in the video regarding Novartis' CAR-T therapy. Thus far, their results appear to have similar safety and efficacy as other products). Updated report can be seen here: www.lupusencyclopedia.com/car-t-cell-therapy-for-lupus/
Thanks so much for doing this and keeping us apprised. 👍
Since the video taping (as of April 2024), additional data have been published and at least 43 SLE patients have been reported treated with CAR-T cell therapy. Almost all developed mild, easy-to-treat cytokine release syndrome (most common symptom was fever). Therefore, Dr. Thomas retracts his statement in the video regarding Novartis' CAR-T therapy. Thus far, their results appear to have similar safety and efficacy as other products). Updated report can be seen here: www.lupusencyclopedia.com/car-t-cell-therapy-for-lupus/